By Steve Usdin
Contributing Editor

WASHINGTON - An independent review of the FIAU disaster conducted by the Institute of Medicine of the National Academy of Sciences has absolved the drug's sponsors, Eli Lilly and Co. and Oclassen Pharmaceuticals, of any responsibility, and concluded that the incident was an "unavoidable tragedy." The IOM report also criticized the FDA's response, warning that it could seriously impede new drug development.